Taimoor Hashim is a Cardiology physician. OpenAlex indexes 25 publications with 485 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2055 E South Blvd Ste 403
Montgomery, AL 361162098
Telephone
334-613-0807Registry record last updated 2 Aug 2019.
Industry payments
31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- ABIOMEDProgram year20251 payment
- PFIZER INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.8%Beta blocker17.4%Carvedilol43%Metoprolol Succinate38%Metoprolol Tartrate16%Atenolol3%Part D<11 patientsStatin12%Atorvastatin Calcium82%Rosuvastatin Calcium10%Pravastatin Sodium8%Part D<11 patients+ 15 more classes in this area
Blood & clotting
22.8%Factor Xa inhibitor13.9%Eliquis83%Xarelto17%Part D≥93 patientsP2Y12 inhibitor8.4%Clopidogrel62%Prasugrel Hcl22%Brilinta16%Part D≥65 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.7%Potassium supplement1.4%Potassium Chloride100%Part D≥18 patientsProton pump inhibitor1.1%Pantoprazole Sodium100%Part D≥12 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Targeted Temperature Management; Review of Literature and Guidelines; A Cardiologist's Perspective
Current Cardiology Reviews
2018 - INITIATION OF LOOP DIURETICS HAS NO ASSOCIATION WITH 30-DAY ALL-CAUSE OR HEART FAILURE READMISSIONS OR ALL-CAUSE MORTALITY IN OLDER MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE
Journal of the American College of Cardiology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”